DMAM
LPCN icon

Del Mar Asset Management’s Lipocine LPCN Stock Holding History

Del Mar Asset Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.02M Sell
19,452
-156
-0.8% -$19.4K 2.64% 12
2014
Q2 		$2.03M Buy
+19,608
New +$2.34M 0.68% 17

Other funds holding LPCN

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Del Mar Asset Management's LPCN Position: Q3 2014 in Review

Del Mar Asset Management reduced its Lipocine (LPCN) stake by 0.8% in Q3 2014, selling an estimated $19.4K and leaving 19,452 shares worth $2.02M. The position accounts for 2.64% of the portfolio, ranked #12.

Del Mar Asset Management first reported a position in LPCN in Q2 2014 and has held it in 2 quarters since. The position peaked at $2.03M in Q2 2014. 17 funds tracked by Wall St. Rank hold LPCN as of Q3 2014.

  • Del Mar Asset Management held 19,452 shares of Lipocine worth $2.02M as of Q3 2014.
  • Del Mar Asset Management sold 156 Lipocine shares in Q3 2014, an estimated $19.4K.
  • Lipocine made up 2.64% of Del Mar Asset Management's portfolio in Q3 2014, its #12 holding.
  • Del Mar Asset Management first reported a position in Lipocine in Q2 2014 and has held it in 2 quarters since.
  • Del Mar Asset Management's Lipocine position peaked at $2.03M in Q2 2014.
  • 17 funds tracked by Wall St. Rank held Lipocine as of Q3 2014.

Based on Del Mar Asset Management's 13F filing for Q3 2014, filed 10 Nov 2014.